Jenny Chen > McDermott Will & Emery LLP > Boston, United States > Lawyer Profile
McDermott Will & Emery LLP Offices
28 STATE STREET
BOSTON, MA 02109-1775
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Jenny Chen
Work Department
Healthcare
Position
Jiayan Chen is deeply experienced in the regulatory, transactional and strategic issues that arise when leveraging health information, biospecimens and technology to drive healthcare innovation and quality. She guides stakeholders on privacy compliance and research compliance and in the context of strategic initiatives and collaborations as they seek to harness the power of data, machine learning, DNA sequencing and technologies to develop and deploy new products and solutions and address challenges in healthcare delivery and payment.
Her extensive work with complex and cutting-edge Big Data transactions and initiatives, real-world data and evidence generation, and data and health information technology transactions, and experience in data protection, genomic privacy, and research compliance make her extremely sought after in the industry. Jiayan advises a broad range of clients, including healthcare and life sciences companies, academic medical centers, genetics companies, digital health companies, data companies and healthcare technology companies, on a wide range of issues that arise at the intersection of health data, biospecimens, and technology.
She counsels clients on data privacy requirements under US federal and state law, including the Health Insurance Portability and Accountability Act (HIPAA), and various state genetic and other health information privacy laws, and the General Data Protection Regulation (GDPR). Jiayan provides guidance on research compliance and development, including preparation of protocols and informed consent and authorizations, as well as institutional, sponsor, and IRB compliance with the Common Rule and FDA Good Clinical Practices. She also works with clients on mapping and implementing data use and sharing strategies with the appropriate data governance and programmatic safeguards.
In addition, Jiayan’s practice includes counseling life sciences companies and healthcare providers on state and federal “Sunshine” and gift ban laws. In this regard, she analyzes proposed arrangements and corporate organizational structures for purposes of identifying and informing reporting obligations, and helps clients develop compliance mechanisms for managing their reporting obligations.
Lawyer Rankings
United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
Silicon Valley-based intellectual property head William Gaede, Chicago-based patent prosecution head Ahsan Shaikh, who leads on a number of the team’s prominent matters, and Boston-based IP transactions and licensing head Edward Gordon , are key leaders of the team at McDermott Will & Emery LLP, with Silicon Valley’s Judy Mohr particularly focused on pharmaceutical and medical device matters, developing and defending portfolios for clients in these industries. The team continues to represent major clients such as Meta and related platforms, Panasonic and EA, with Boston’s Jenny Chen and Michael Siekman leading on key matters, an example being the multi-jurisdictional life sciences patent prosecution matter regarding a number of CRISPR Therapeutics’ lead programs. Partner Margaret Sampson notably joined the team in Austin, Texas from Baker Botts L.L.P. in July 2022.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Technology transactions
- Healthcare > Health insurers
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- Insurance > Advice to insurers
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: electric power
- Tax > Financial products
- Labor and employment > Immigration
- Tax > International tax
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Labor and employment > Labor-management relations
- Antitrust > Merger control
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Real estate > Real estate finance
- International Trade > Trade remedies and trade policy
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Labor and employment > Labor and employment disputes (including collective actions)
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: derivatives and structured products
- Dispute resolution > Corporate investigations and white-collar criminal defense
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Government > Government contracts
- Finance > Fintech
- Investment fund formation and management > Alternative/hedge funds